BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15289853)

  • 1. Deletion and aberrant CpG island methylation of Caspase 8 gene in medulloblastoma.
    Gonzalez-Gomez P; Bello MJ; Inda MM; Alonso ME; Arjona D; Amiñoso C; Lopez-Marin I; de Campos JM; Sarasa JL; Castresana JS; Rey JA
    Oncol Rep; 2004 Sep; 12(3):663-6. PubMed ID: 15289853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic changes in pilocytic astrocytomas and medulloblastomas.
    Gonzalez-Gomez P; Bello MJ; Lomas J; Arjona D; Alonso ME; Amiñoso C; De Campos JM; Vaquero J; Sarasa JL; Casartelli C; Rey JA
    Int J Mol Med; 2003 May; 11(5):655-60. PubMed ID: 12684707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-8 gene expression in neuroblastoma.
    Casciano I; Banelli B; Croce M; De Ambrosis A; di Vinci A; Gelvi I; Pagnan G; Brignole C; Allemanni G; Ferrini S; Ponzoni M; Romani M
    Ann N Y Acad Sci; 2004 Dec; 1028():157-67. PubMed ID: 15650242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development.
    Lusher ME; Lindsey JC; Latif F; Pearson AD; Ellison DW; Clifford SC
    Cancer Res; 2002 Oct; 62(20):5906-11. PubMed ID: 12384556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
    Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
    Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Risk stratification in medulloblastoma: screening for molecular markers].
    Ebinger M; Senf L; Scheurlen W
    Klin Padiatr; 2006; 218(3):139-42. PubMed ID: 16688669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
    Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
    Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor.
    Pang JC; Chang Q; Chung YF; Teo JG; Poon WS; Zhou LF; Kong X; Ng HK
    Hum Pathol; 2005 Jan; 36(1):36-43. PubMed ID: 15712180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors.
    Bello MJ; Alonso ME; Amiñoso C; Anselmo NP; Arjona D; Gonzalez-Gomez P; Lopez-Marin I; de Campos JM; Gutierrez M; Isla A; Kusak ME; Lassaletta L; Sarasa JL; Vaquero J; Casartelli C; Rey JA
    Mutat Res; 2004 Oct; 554(1-2):23-32. PubMed ID: 15450401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
    Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
    Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
    Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
    Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter methylation pattern of caspase-8, P16INK4A, MGMT, TIMP-3, and E-cadherin in medulloblastoma.
    Ebinger M; Senf L; Wachowski O; Scheurlen W
    Pathol Oncol Res; 2004; 10(1):17-21. PubMed ID: 15029256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs.
    Frühwald MC; O'Dorisio MS; Dai Z; Rush LJ; Krahe R; Smiraglia DJ; Pietsch T; Elsea SH; Plass C
    Genes Chromosomes Cancer; 2001 Jan; 30(1):38-47. PubMed ID: 11107174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic repression of RASSF1A but not CASP8 in supratentorial PNET (sPNET) and atypical teratoid/rhabdoid tumors (AT/RT) of childhood.
    Mühlisch J; Schwering A; Grotzer M; Vince GH; Roggendorf W; Hagemann C; Sörensen N; Rickert CH; Osada N; Jürgens H; Frühwald MC
    Oncogene; 2006 Feb; 25(7):1111-7. PubMed ID: 16186793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme.
    Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M
    Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
    Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
    Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma.
    Rood BR; Zhang H; Weitman DM; Cogen PH
    Cancer Res; 2002 Jul; 62(13):3794-7. PubMed ID: 12097291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation.
    Takada H; Imoto I; Tsuda H; Nakanishi Y; Ichikura T; Mochizuki H; Mitsufuji S; Hosoda F; Hirohashi S; Ohki M; Inazawa J
    Oncogene; 2005 Dec; 24(54):8051-60. PubMed ID: 16103878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas.
    Gonzalez-Gomez P; Bello MJ; Arjona D; Alonso ME; Lomas J; De Campos JM; Kusak ME; Gutierrez M; Sarasa JL; Rey JA
    Oncol Rep; 2003; 10(5):1519-23. PubMed ID: 12883734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of genetic and epigenetic mechanisms to gene silencing in oligodendrogliomas.
    Hong C; Bollen AW; Costello JF
    Cancer Res; 2003 Nov; 63(22):7600-5. PubMed ID: 14633674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.